Author
Listed:
- Suneet Agarwal
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Yuin-Han Loh
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Erin M. McLoughlin
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Junjiu Huang
(MDC 3125, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, USA
State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China)
- In-Hyun Park
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Justine D. Miller
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Hongguang Huo
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Maja Okuka
(MDC 3125, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, USA)
- Rosana Maria dos Reis
(MDC 3125, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, USA)
- Sabine Loewer
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute)
- Huck-Hui Ng
(Gene Regulatory Laboratory, National University of Singapore; 60 Biopolis Street, #02-01, Genome, Singapore 138672
National University of Singapore)
- David L. Keefe
(MDC 3125, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, USA)
- Frederick D. Goldman
(The Children’s Hospital of Alabama, 1600 7th Avenue South, ACC 512, Birmingham, Alabama 35233, USA)
- Aloysius J. Klingelhutz
(University of Iowa, 2202 MERF, 375 Newton Road, Iowa City, Iowa 52242, USA)
- Lin Liu
(MDC 3125, University of South Florida College of Medicine, 12901 Bruce B. Downs Boulevard, Tampa, Florida 33612, USA
College of Life Sciences, Nankai University)
- George Q. Daley
(Children’s Hospital Boston; Pediatric Oncology, Brigham and Women’s Hospital; Harvard Stem Cell Institute; Manton Center for Orphan Disease Research; Boston, Massachusetts 02115, USA
Pediatric Oncology, Dana Farber Cancer Institute
Howard Hughes Medical Institute, Children’s Hospital Boston, Karp Family Research Building 07214, 1 Blackfan Circle, Boston, Massachusetts 02115, USA)
Abstract
Restoring telomere elongation in dyskeratosis congenita Patients with dyskeratosis congenita, a disorder of telomere maintenance, suffer degeneration of multiple tissues. Agarwal et al. use iPS (induced pluripotent stem) cell technology to study the mechanisms underlying the disease in humans, and in doing so they discover that reprogramming restores telomere elongation in dyskeratosis congenita cells despite genetic lesions affecting telomerase. The reprogrammed dyskeratosis congenita cells were able to overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal, and multiple telomerase components are targeted by pluripotency-associated transcription factors. Strategies designed to increase TERC expression may therefore be therapeutically beneficial in dyskeratosis congenita patients.
Suggested Citation
Suneet Agarwal & Yuin-Han Loh & Erin M. McLoughlin & Junjiu Huang & In-Hyun Park & Justine D. Miller & Hongguang Huo & Maja Okuka & Rosana Maria dos Reis & Sabine Loewer & Huck-Hui Ng & David L. Keefe, 2010.
"Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients,"
Nature, Nature, vol. 464(7286), pages 292-296, March.
Handle:
RePEc:nat:nature:v:464:y:2010:i:7286:d:10.1038_nature08792
DOI: 10.1038/nature08792
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:464:y:2010:i:7286:d:10.1038_nature08792. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.